News & Events

In this section

Toxicology Research Laboratory Chooses Instem Software Solutions

Chicago based Contract Research Organization Selects Instem's Provantis Preclinical Study Management and submit-SEND software

CONSHOHOCKEN, PA - (BUSINESS WIRE) – October 28, 2014 - -Instem, a leading provider of IT solutions to the global early development healthcare market, announced today that Toxicology Research Laboratory (TRL) has purchased the Provantis® software suite for managing their preclinical studies, along with the submit™ solution suite to support CDISC’s Standard for Exchange of Nonclinical Data (SEND).

TRL is a GLP operated, AAALAC International accredited facility located within the University of Illinois at Chicago. TRL has conducted many preclinical toxicology programs on potential therapeutic agents and other chemicals. Organizations such as the National Cancer Institute, the World Health Organization, the U.S. Army Medical Research and Development Command, and several biotechnology, pharmaceutical, and agricultural companies utilize the expertise and commitment of the interdisciplinary TRL team.

TRL selected Provantis to replace their existing preclinical software with a more modern, robust and efficient integrated system that would also deliver improved regulatory reporting capabilities.

TRL’s selection of Instem’s submit solution suite will allow them to fully support CDISC’s SEND initiative. SEND defines the organization, structure, and format of standard nonclinical tabulation datasets and enables more efficient review of study data while helping to improve data quality, accessibility and predictability. Submit will enable TRL to convert data from any source system into SEND files, allowing them to share, visualize and analyze study data with their sponsors and regulators more efficiently.

Key Facts

  • Provantis chosen to replace aging legacy solution
  • TRL deploying a range of Provantis version 9 modules including General Toxicology, Pathology, Tables & Statistics and Clinical Pathology instrument interfaces
  • Submit™ solution chosen to create, convert, visualize and share SEND data
  • Specialized Solutions program selected for rapid deployment, using a more tailored approach to implementation, training, validation and support

Matt Lindeblad, Study Director & Senior Toxicologist, TRL said “We were seeking a world leading solution to help us deliver the next level of efficiencies within our laboratory and to enable us to further improve our level of client service. Using Provantis we believe we have found such a solution and look forward to seeing the benefits of our investment.”  Mr. Lindeblad continued “In addition, as we gear up for the SEND initiative, we look forward to joining the numerous organizations that are now utilizing Instem solutions to create and manage SEND data sets.”

Ed Lorenti, VP Global Sales, Instem added “We are delighted to welcome TRL as our newest client. We look forward to forging a long and successful relationship with TRL and are pleased to help them advance their mission of providing the highest levels of client service and responsiveness to their customer base.”

About Toxicology Research Laboratory

Toxicology Research Laboratory (TRL) is an independent contract research laboratory located within the Department of Pharmacology at the University of Illinois at Chicago (UIC). TRL offers a GLP compliant and AAALAC accredited facility for performing a range of preclinical services including General Toxicology, Pharmacokinetics, Reproductive Toxicology, ADME, Genotoxicity and Efficacy Studies, In-Vitro and In-Vivo Toxicology and Analytical and Bio analytical Support. TRL is located in the middle of the “Illinois Medical District”, within close proximity of 4 major hospitals, giving TRL the opportunity to collaborate with world renowned experts in specific areas of research. By offering the resources of a major State University and UIC Hospital System with a wide range of experienced staff, professors and other leading medical specialists, TRL can propose an endless variety of disease models and conduct preclinical studies seamlessly in conjunction with clinical trials at the UIC General Research Center to evaluate potential drugs.

To learn more about TRL, please visit trl.uic.edu/home

About Instem

Instem is a leading supplier of IT applications to the early development healthcare market delivering compelling solutions for data collection, management and analysis across the R&D continuum. Instem applications are in use by customers worldwide, meeting the rapidly expanding needs of life science and healthcare organizations for data-driven decision making leading to safer, more effective products.

Instem’s portfolio of software solutions increases client productivity by automating study-related processes while offering the unique ability to generate new knowledge through the extraction and harmonization of actionable scientific information.

Instem supports over 400 clients through full service offices in the United States, United Kingdom and China with additional locations in India and a full service distributor based in Japan.

Meeting clients at the intersection of investment & return™.

Press Contacts:

Instem
Gary Mitchell (US HQ)
gary.mitchell@instem.com
Tel: 610-941-0990

Julie Jones (UK HQ)
julie.jones@instem.com
Tel: +44 (0) 1785 825600